» Articles » PMID: 35189946

Between Two Stools: Preclinical Research, Reproducibility, and Statistical Design of Experiments

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2022 Feb 22
PMID 35189946
Authors
Affiliations
Soon will be listed here.
Abstract

Translation of animal-based preclinical research is hampered by poor validity and reproducibility issues. Unfortunately, preclinical research has 'fallen between the stools' of competing study design traditions. Preclinical studies are often characterised by small sample sizes, large variability, and 'problem' data. Although Fisher-type designs with randomisation and blocking are appropriate and have been vigorously promoted, structured statistically-based designs are almost unknown. Traditional analysis methods are commonly misapplied, and basic terminology and principles of inference testing misinterpreted. Problems are compounded by the lack of adequate statistical training for researchers, and failure of statistical educators to account for the unique demands of preclinical research. The solution is a return to the basics: statistical education tailored to non-statistician investigators, with clear communication of statistical concepts, and curricula that address design and data issues specific to preclinical research. Statistics curricula should focus on statistics as process: data sampling and study design before analysis and inference. Properly-designed and analysed experiments are a matter of ethics as much as procedure. Shifting the focus of statistical education from rote hypothesis testing to sound methodology will reduce the numbers of animals wasted in noninformative experiments and increase overall scientific quality and value of published research.

Citing Articles

Standardized Protocol for Resazurin-Based Viability Assays on A549 Cell Line for Improving Cytotoxicity Data Reliability.

Petiti J, Caria S, Revel L, Pegoraro M, Divieto C Cells. 2024; 13(23).

PMID: 39682708 PMC: 11640476. DOI: 10.3390/cells13231959.


Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer's disease research.

Granzotto A, Vissel B, Sensi S Elife. 2024; 13.

PMID: 39329365 PMC: 11434637. DOI: 10.7554/eLife.90633.


Design and validation of novel flow cytometry panels to analyze a comprehensive range of peripheral immune cells in mice.

Barco-Tejada A, Lopez-Esteban R, Mulero F, Pion M, Correa-Rocha R, Desco M Front Immunol. 2024; 15:1432816.

PMID: 39206202 PMC: 11350558. DOI: 10.3389/fimmu.2024.1432816.


Building reproducible bridges to cross the "valley of death".

Errington T J Clin Invest. 2024; 134(1).

PMID: 38165039 PMC: 10760970. DOI: 10.1172/JCI177383.


Reproducibility and Scientific Integrity of Big Data Research in Urban Public Health and Digital Epidemiology: A Call to Action.

Quiroga Gutierrez A, Lindegger D, Taji Heravi A, Stojanov T, Sykora M, Elayan S Int J Environ Res Public Health. 2023; 20(2).

PMID: 36674225 PMC: 9861515. DOI: 10.3390/ijerph20021473.

References
1.
Festing M . The "completely randomised" and the "randomised block" are the only experimental designs suitable for widespread use in pre-clinical research. Sci Rep. 2020; 10(1):17577. PMC: 7567855. DOI: 10.1038/s41598-020-74538-3. View

2.
Diong J, Butler A, Gandevia S, Heroux M . Poor statistical reporting, inadequate data presentation and spin persist despite editorial advice. PLoS One. 2018; 13(8):e0202121. PMC: 6093658. DOI: 10.1371/journal.pone.0202121. View

3.
Marcus E . A STAR Is Born. Cell. 2016; 166(5):1059-1060. DOI: 10.1016/j.cell.2016.08.021. View

4.
. The '3Is' of animal experimentation. Nat Genet. 2012; 44(6):611. DOI: 10.1038/ng.2322. View

5.
Macleod M, Lawson McLean A, Kyriakopoulou A, Serghiou S, de Wilde A, Sherratt N . Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biol. 2015; 13(10):e1002273. PMC: 4603955. DOI: 10.1371/journal.pbio.1002273. View